A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis

References

• Porock D, Kristjanson L. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. Eur J Cancer Care. 1999;8:143–153.
   PubMed Web of Science ®Google Scholar
• Porock D, Kristjanson L, Nikoletti S, et al. Predicting the severity of radiation skin reactions in women with breast cancer. Oncol Nurs Forum. 1998;25(6):1019–1029.
   PubMedGoogle Scholar
• Yamazaki H, Yoshida K, Nishimura T, et al. Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation. J Radiat Res. 2011;52:496–501.
   PubMed Web of Science ®Google Scholar
• Ryan JL, Bole C, Hickok JT, et al. Post treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations. Br J Cancer. 2007;97(1):14–21.
   PubMed Web of Science ®Google Scholar
• Chan R, Webster J, Chung B, et al. Prevention and treatment of acute radiation induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer. 2014;14:53.
   PubMed Web of Science ®Google Scholar
• Beetz A, Messer G, Oppel T, et al. Induction of interleukin 6 by ionizing radiation in a human epithelial cell line: control by corticosteroids. Int J Radiat Biol. 1997;72(1):33–43.
   PubMed Web of Science ®Google Scholar
• Meghrajani C, Co H, Ang-Tiu C, et al. Topical corticosteroid therapy for the prevention of acute radiation dermatitis: a systematic review of randomized controlled trials. Exp Rev Clin Pharmacol. 2013;6(6):641–649.
   PubMed Web of Science ®Google Scholar
• Omidvari S, Saboori H, Mohammadianpanah M, et al. Topical betamethasone for prevention of radiodermatitis. Indian J Dermatol Venereol Leprol. 2007;73(3):209–215.
   PubMedGoogle Scholar
• Shukla PN, Gairola M, Mohanti BK, et al. Prophylactic beclomethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study. Indian J Cancer. 2006;43(4):180–184.
   PubMedGoogle Scholar
• Schmuth M, Wimmer MA, Hofer S, et al. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized double blind study. Br J Dermatol. 2002;146:983–991.
   PubMed Web of Science ®Google Scholar
• Bostrom A, Lindman H, Swartling C, et al. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double blind randomized study. Radiother Oncol. 2001;59:257–265.
   PubMed Web of Science ®Google Scholar
• Farhan F, Kazemian A, Alagheband H. Topical betamethasone for the prevention of acute radiation dermatitis in breast cancer patients. Iran J Radiat Res. 2003;1(2):105–111.
   Google Scholar
• Miller R, Schwartz D, Sloan J, et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients: a phase 3 randomized double blind trial from the north central cancer treatment group. Int J Radiat Oncol Biol Phys. 2011;49(5):1460–1466.
   Web of Science ®Google Scholar
• Warner M, Camisa C. Topical corticosteroids. In: Wolverton S, editor. Comprehensive dermatologic drug therapy. USA: W.B. Saunders; 2001.
   Google Scholar
• Fitzpatrick T. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–871.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 3.0. USA: NCI, NIH, DHHS; 2006 August.
   Google Scholar
• Rosenstein B. The biologic basis of therapy. In: Haffty B, Wilson L, editors. Handbook of radiation oncology: basic principles and clinical protocols. USA: Jones and Bartlett; 2008.
   Google Scholar
• Mutyala S, Wolfson A. Cervical cancer. In: Lu J, Brady L, editors. Radiation oncology: an evidence-based approach. New York: Springer; 2008.
   Google Scholar
• Altoparlak U, Koca O, Koca T. Incidence and risk factors of the secondary skin infections in patients with radiodermatitis. EAJM. 2011;43:177–181.
   Google Scholar
• Chen M, Chen W, Lai C, et al. Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer. 2010;10:508–516.
   PubMed Web of Science ®Google Scholar
• Stander S, Steinhoff M, Schmelz M, et al. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol. 2003;139:1463–1470.
   PubMedGoogle Scholar
• Moriyasu S, Yamamoto K, Kureyama N, et al. Involvement of histamine released from mast cells in acute radiation dermatitis in mice. J Pharmacol Sci. 2007;104:187–190.
   PubMed Web of Science ®Google Scholar
• Lavker RM, Schechter NM. Cutaneous mast cell depletion results from topical corticosteroid usage. J of Immunol. 1985;135(4):2368–2373.
   PubMed Web of Science ®Google Scholar
• Barton J, Lavker RM, Schechter NM, et al. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol. 1985;121(12):1516–1523.
   PubMedGoogle Scholar
• Kinnaert E, Morandini R, Simon S, et al. The degree of pigmentation modulates the radiosensitivity of human melanoma cells. Radiat Res. 2000;154(5):497–502.
   PubMed Web of Science ®Google Scholar
• Kostanecki W, Radman I, Mroczkowski T. The effect of x-ray irradiation upon the epithelial melanin unit of the hair bulb in hooded rat. Arch Dermatol Res. 1976;256(3):297–303.
   PubMed Web of Science ®Google Scholar
• Brozyna A, Van Middlesworth L, Slominski A. Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy. Int J Cancer. 2008;123:1448–1456.
   PubMed Web of Science ®Google Scholar
• Kvam E, Tyrrell R. The role of melanin in the induction of oxidative DNA base damage by ultraviolet A irradiation of DNA or melanoma cells. J Invest Dermatol. 1999;113(2):209–213.
   PubMed Web of Science ®Google Scholar
• Smit N, Van Nieuwpoort F, Marrot L, et al. Increased melanogenesis is a risk factor for oxidative DNA damage: study on cultured melanocytes and atypical nevus cells. Photochem Photobiol. 2008;84(3):550–555.
   PubMed Web of Science ®Google Scholar
• Simon J, Peles D, Wakamatsu K, et al. Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function. Pigment Cell Melanoma Res. 2009;22:562–579.
   Web of Science ®Google Scholar